Avalyn Pharma Inc. (AVLN) Insider Trading

3 insiders at Avalyn Pharma Inc. (AVLN) have purchased stock in the past 90 days, totaling $25.0M across 4 transactions (1,388,888 shares).

The most recent purchase was by 10%+ Owner Novo Holdings A/S on May 1, 2026 — a $10.0M buy of 555,555 shares at $18.00, bringing his total holdings to 3,883,289 shares.

Insiders who purchased: Novo Holdings A/S (10%+ Owner, 1 buy totaling $10.0M); SR ONE CAPITAL MANAGEMENT, LLC (10%+ Owner, 2 buys totaling $10.0M); Carroll Jill (Director, 1 buy totaling $5.0M).

This insider buying is notable given that AVLN had no recorded open market purchases in the nine months before that.

AVLN is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $1.3B.

With 3 different insiders buying in the same 90-day window, this qualifies as cluster buying at AVLN — a pattern that research suggests can signal conviction among management.

Track AVLN insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.